Literature DB >> 15917643

Detection of sumoylated proteins.

Roland S Hilgarth1, Kevin D Sarge.   

Abstract

Small ubiquitin-related modifier (SUMO) is an ubiquitin-like protein that is covalently attached to a variety of target proteins. Unlike ubiquitination, sumoylation does not target proteins for proteolytic breakdown, but is involved in regulation of protein function, nuclear targeting, and the formation of subcellular structures. Because SUMO is involved in such a plethora of functions and modifies numerous proteins it is important to identify proteins that are sumoylated in order to increase our understanding of how this modification affects protein function and localization. This overview describes techniques utilized for the detection of sumoylated proteins. The techniques covered include immunoprecipitation, an in vitro sumoylation assay, and gel shift mobility assays that have been used to identify SUMO-modified proteins.

Mesh:

Substances:

Year:  2005        PMID: 15917643      PMCID: PMC2923543          DOI: 10.1385/1-59259-895-1:329

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  15 in total

1.  SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting.

Authors:  M S Rodriguez; C Dargemont; R T Hay
Journal:  J Biol Chem       Date:  2000-12-21       Impact factor: 5.157

2.  Ubc9p is the conjugating enzyme for the ubiquitin-like protein Smt3p.

Authors:  E S Johnson; G Blobel
Journal:  J Biol Chem       Date:  1997-10-24       Impact factor: 5.157

Review 3.  SUMO: a history of modification.

Authors:  Ronald T Hay
Journal:  Mol Cell       Date:  2005-04-01       Impact factor: 17.970

Review 4.  Modification of proteins by ubiquitin and ubiquitin-like proteins.

Authors:  Oliver Kerscher; Rachael Felberbaum; Mark Hochstrasser
Journal:  Annu Rev Cell Dev Biol       Date:  2006       Impact factor: 13.827

5.  The ubiquitin-like protein Smt3p is activated for conjugation to other proteins by an Aos1p/Uba2p heterodimer.

Authors:  E S Johnson; I Schwienhorst; R J Dohmen; G Blobel
Journal:  EMBO J       Date:  1997-09-15       Impact factor: 11.598

6.  Ubch9 conjugates SUMO but not ubiquitin.

Authors:  J M Desterro; J Thomson; R T Hay
Journal:  FEBS Lett       Date:  1997-11-17       Impact factor: 4.124

7.  Molecular cloning and characterization of human AOS1 and UBA2, components of the sentrin-activating enzyme complex.

Authors:  L Gong; B Li; S Millas; E T Yeh
Journal:  FEBS Lett       Date:  1999-04-01       Impact factor: 4.124

8.  Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9.

Authors:  M H Tatham; E Jaffray; O A Vaughan; J M Desterro; C H Botting; J H Naismith; R T Hay
Journal:  J Biol Chem       Date:  2001-07-12       Impact factor: 5.157

9.  In vitro SUMO-1 modification requires two enzymatic steps, E1 and E2.

Authors:  T Okuma; R Honda; G Ichikawa; N Tsumagari; H Yasuda
Journal:  Biochem Biophys Res Commun       Date:  1999-01-27       Impact factor: 3.575

10.  SUMO: regulating the regulator.

Authors:  Guillaume Bossis; Frauke Melchior
Journal:  Cell Div       Date:  2006-06-29       Impact factor: 5.130

View more
  13 in total

1.  MEL-18 interacts with HSF2 and the SUMO E2 UBC9 to inhibit HSF2 sumoylation.

Authors:  Jie Zhang; Michael L Goodson; Yiling Hong; Kevin D Sarge
Journal:  J Biol Chem       Date:  2008-01-21       Impact factor: 5.157

2.  DeSUMOylation switches Kaiso from activator to repressor upon hyperosmotic stress.

Authors:  Svetlana Zhenilo; Igor Deyev; Ekaterina Litvinova; Nadezhda Zhigalova; Daria Kaplun; Alexey Sokolov; Alexander Mazur; Egor Prokhortchouk
Journal:  Cell Death Differ       Date:  2018-02-22       Impact factor: 15.828

3.  Ehrlichia chaffeensis exploits host SUMOylation pathways to mediate effector-host interactions and promote intracellular survival.

Authors:  Paige Selvy Dunphy; Tian Luo; Jere W McBride
Journal:  Infect Immun       Date:  2014-07-21       Impact factor: 3.441

4.  Pro-invasive properties of Snail1 are regulated by sumoylation in response to TGFβ stimulation in cancer.

Authors:  Shyam Kumar Gudey; Reshma Sundar; Carl-Henrik Heldin; Anders Bergh; Marene Landström
Journal:  Oncotarget       Date:  2017-08-09

5.  The homeodomain-interacting protein kinase HPK-1 preserves protein homeostasis and longevity through master regulatory control of the HSF-1 chaperone network and TORC1-restricted autophagy in Caenorhabditis elegans.

Authors:  Ritika Das; Justine A Melo; Manjunatha Thondamal; Elizabeth A Morton; Adam B Cornwell; Beresford Crick; Joung Heon Kim; Elliot W Swartz; Todd Lamitina; Peter M Douglas; Andrew V Samuelson
Journal:  PLoS Genet       Date:  2017-10-16       Impact factor: 5.917

6.  SUMO-mediated regulation of NLRP3 modulates inflammasome activity.

Authors:  Rachael Barry; Sidonie Wicky John; Gianmaria Liccardi; Tencho Tenev; Isabel Jaco; Chih-Hong Chen; Justin Choi; Paulina Kasperkiewicz; Teresa Fernandes-Alnemri; Emad Alnemri; Marcin Drag; Yuan Chen; Pascal Meier
Journal:  Nat Commun       Date:  2018-08-01       Impact factor: 14.919

7.  Composition of the Intranuclear Inclusions of Fragile X-associated Tremor/Ataxia Syndrome.

Authors:  Lisa Ma; Anthony W Herren; Glenda Espinal; Jamie Randol; Bridget McLaughlin; Veronica Martinez-Cerdeño; Isaac N Pessah; Randi J Hagerman; Paul J Hagerman
Journal:  Acta Neuropathol Commun       Date:  2019-09-03       Impact factor: 7.801

8.  The lncRNA BORG Drives Breast Cancer Metastasis and Disease Recurrence.

Authors:  Alex J Gooding; Bing Zhang; Fereshteh Kenari Jahanbani; Hannah L Gilmore; Jenny C Chang; Saba Valadkhan; William P Schiemann
Journal:  Sci Rep       Date:  2017-10-05       Impact factor: 4.379

9.  Sumoylation in p27kip1 via RanBP2 promotes cancer cell growth in cholangiocarcinoma cell line QBC939.

Authors:  Jun Yang; Yan Liu; Bing Wang; Hongzhen Lan; Ying Liu; Fei Chen; Ju Zhang; Jian Luo
Journal:  BMC Mol Biol       Date:  2017-09-07       Impact factor: 2.946

10.  Telomeric Repeat-Binding Factor Homologs in Entamoeba histolytica: New Clues for Telomeric Research.

Authors:  Francisco Javier Rendón-Gandarilla; Víctor Álvarez-Hernández; Elizabeth J Castañeda-Ortiz; Helios Cárdenas-Hernández; Rosa Elena Cárdenas-Guerra; Jesús Valdés; Abigail Betanzos; Bibiana Chávez-Munguía; Anel Lagunes-Guillen; Esther Orozco; Lilia López-Canovas; Elisa Azuara-Liceaga
Journal:  Front Cell Infect Microbiol       Date:  2018-10-02       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.